
ImageBiopsy Lab is a leading AI-driven software company specializing in musculoskeletal (MSK) imaging intelligence. Founded in 2016, it offers a modular AI platform that automates and standardizes MSK diagnostics on radiographs, providing fast, quantitative, and objective reports for orthopedists and radiologists. Its product portfolio includes solutions for knee, hip, leg, hand, and spine imaging, with CE and FDA certifications, installed in over 100 sites across Europe and the US. The company integrates AI into existing radiological workflows to improve diagnostic accuracy, reduce manual work, and support early detection and monitoring of bone diseases. It serves physicians, research organizations, and pharmaceutical companies, aiming to improve patient outcomes globally through innovative AI technology and continuous product development.

ImageBiopsy Lab is a leading AI-driven software company specializing in musculoskeletal (MSK) imaging intelligence. Founded in 2016, it offers a modular AI platform that automates and standardizes MSK diagnostics on radiographs, providing fast, quantitative, and objective reports for orthopedists and radiologists. Its product portfolio includes solutions for knee, hip, leg, hand, and spine imaging, with CE and FDA certifications, installed in over 100 sites across Europe and the US. The company integrates AI into existing radiological workflows to improve diagnostic accuracy, reduce manual work, and support early detection and monitoring of bone diseases. It serves physicians, research organizations, and pharmaceutical companies, aiming to improve patient outcomes globally through innovative AI technology and continuous product development.
Founded: 2016
Headquarters: Vienna, Austria
Product focus: AI software for musculoskeletal (MSK) imaging analysis
Regulatory status: CE and FDA-targeted modules
Deployments: Installed at 100+ sites across Europe and the US
Musculoskeletal imaging diagnostics and radiology workflow optimization.
2016
Medtech / Medical imaging AI
Latest round reported on 2023-07-31; public profiles list multiple investors including IT-Farm and aws Gründungsfonds.
“Has multiple institutional backers (listed investors include IT-Farm and aws Gründungsfonds)”